Cancer procoagulant (CP) in surgical oncology diagnostics
Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 10
Abstract
A considerable advancement of the neoplastic process at the start of the treatment is one of the major reasons of high mortality caused by malignant neoplasms. Numerous studies have been devoted to the diagnosis of cancer at its earliest stage, as the earliest administration of treatment tremendously increases chances of patients for total recovery. A considerable progress in oncological diagnostics has been observed since 1846, when the protein test of Bence-Jones was used in the diagnostics of multiple myeloma, for the first time. In the following decades, neoplastic markers were isolated and described. Since the discovery of carcinoembryonal antigen (CEA) and alpha – fetoprotein (AFP), which appeared to be a breakthrough in the research of neoplastic markers, determination of neoplastic markers has been introduced to the routine oncological diagnostics. At present, neoplastic markers, next to clinical examination and scanning (ultrasound, computed tomography, and magnetic resonance imaging) play an important role in detecting and monitoring malignant neoplasms. A significant increase of CP activity in the serum (in comparison to healthy persons) was found in many cancers of the gastrointestinal tract (oesophagus, stomach, liver, pancreas, colon) and the thyroid. The results of our own and other studies, show that examination of the CP activity could be used as a marker in oncological diagnostics.
Authors and Affiliations
Sławomir Szajda, Jadwiga Snarska, Zdzisław Skrzydlewski, Krzysztof Zwierz
Keywords
Related Articles
- EP ID EP107375
- DOI -
- Views 61
- Downloads 0
Importance of soluble cytokine receptors for inflammation associated cancer
Cytokine receptors, which exist in membrane-bound and soluble form, bind their ligands with comparable affinity. While most soluble receptors are antagonists in that they compete for the ligands with their membrane count...
New agents in treatment of metastatic renal cell carcinoma
As renal cell carcinoma appears to be resistant to conventional treatment modalities and results of cytokine-based immunotherapy are far from satisfactory, there is desperate need for new active agents to be discovered....
Rola radioterapii w leczeniu chorych z przerzutami raka płaskonabłonkowego do węzłów chłonnych szyjnych z nieznanego ogniska pierwotnego
Przedstawiono wyniki retrospektywnej analizy grupy 127 chorych z przerzutami raka płaskonabłonkowego do węzłów chłonnych szyjnych z nieznanego ogniska pierwotnego, leczonych radykalnie w Centrum Onkologii w Krakowie w la...
Postępy w leczeniu przewlekłej białaczki limfocytowej B-komórkowej
Przewlekła białaczka limfocytowa B-komórkowa stanowi ok. 20–30% wszystkich białaczek u dorosłych. W 90% przypadków zachorowania dotyczą osób po 60. roku życia, a mężczyźni chorują 2-krotnie częściej niż kobiety. W osta...
cytostatic drugs and their carcinogenicity - occupation risk problem for healthcare workers
Many of cytostatic drugs have mutagenic, teratogenic and carcinogenic properties, with no threshold dose for those effects. These properties make up a potential risk for healthcare workers who are occupationally exposed...